Cormorant Asset Management’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,870	Closed	-$1.56M	–	76
2017 Q1	$1.56M	Hold	2,870	–	–	0.23%	65
2016 Q4	$1.75M	Hold	2,870	–	–	0.24%	64
2016 Q3	$2.05M	Hold	2,870	–	–	0.23%	65
2016 Q2	$2.09M	Buy	2,870 +34	+1%	+$23.4K	0.3%	60
2016 Q1	$1.69M	Hold	2,836	–	–	0.25%	64
2015 Q4	$1.62M	Sell	2,836 -1,754	-38%	-$1.16M	0.19%	64
2015 Q3	$2.57M	Hold	4,590	–	–	0.41%	54
2015 Q2	$3.65M	Hold	4,590	–	–	0.49%	48
2015 Q1	$3.82M	Sell	4,590 -133	-3%	-$103K	0.59%	46
2014 Q4	$3.4M	Hold	4,723	–	–	0.53%	46
2014 Q3	$3.28M	Hold	4,723	–	–	0.68%	40
2014 Q2	$3.98M	Buy	4,723 +29	+0.6%	+$28.9K	1.07%	38
2014 Q1	$7.67M	Buy	+4,694	New	+$5.68M	1.76%	25